NEW YORK (GenomeWeb News) – Avanticell Science said yesterday that it will head a consortium that includes Giltech and Culzean Medical Devices in developing three-dimensional cell-based assay systems for drug discovery research.

Avanticell specializes in cell culture products and services, Culzean Medical Devices designs and makes implantable medical products, and Giltech makes biomaterials and biodegradable products.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.